Consumer Defensive -
Tobacco - NASDAQ - US
$ 1.915
-0.26 %
$ 3.29 M
Market Cap
None
P/E
1. INTRINSIC VALUE
2. FUNDAMENTAL
ANALYSIS
Price Chart XXII
FINANCIALS
Balance Sheet
22nd Century Group, Inc.
| Current Assets | 16.3 M |
| Cash & Short-Term Investments | 2.06 M |
| Receivables | 1.67 M |
| Other Current Assets | 12.5 M |
| Non-Current Assets | 11.2 M |
| Long-Term Investments | 0 |
| PP&E | 5.29 M |
| Other Non-Current Assets | 5.94 M |
| Current Liabilities | 25 M |
| Accounts Payable | 4.44 M |
| Short-Term Debt | 6.62 M |
| Other Current Liabilities | 14 M |
| Non-Current Liabilities | 10.9 M |
| Long-Term Debt | 9.76 M |
| Other Non-Current Liabilities | 1.12 M |
EFFICIENCY
Earnings Waterfall
22nd Century Group, Inc.
| Revenue | 32.2 M |
| Cost Of Revenue | 40.9 M |
| Gross Profit | -8.7 M |
| Operating Expenses | 36.2 M |
| Operating Income | -44.9 M |
| Other Expenses | 95.8 M |
| Net Income | -141 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
22nd Century Group, Inc.
| Net Income | -141 M |
| Depreciation & Amortization | 4.86 M |
| Capital Expenditures | -5.62 M |
| Stock-Based Compensation | 2.68 M |
| Change in Working Capital | -1.74 M |
| Others | 79 M |
| Free Cash Flow | -60.6 M |
Wall Street Analysts Price Targets
22nd Century Group, Inc.
XXII has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
XXII does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
22nd Century Group, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
10.5 K USD 1
3-6 MONTHS
9.83 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
5 months ago
Sep 12, 2024
|
Bought
10.5 K USD
|
FIRESTONE LAWRENCE
Chief Executive Officer
|
+ 39000
|
0.2684 USD |
|
9 months ago
May 30, 2024
|
Bought
9.83 K USD
|
FIRESTONE LAWRENCE
Chief Executive Officer
|
+ 9000
|
1.0921 USD |
|
1 year ago
Jan 05, 2024
|
Bought
17.5 K USD
|
Arno Andrew
Director
|
+ 100000
|
0.1749 USD |
|
1 year ago
Jan 04, 2024
|
Bought
17.4 K USD
|
FIRESTONE LAWRENCE
Chief Executive Officer
|
+ 100000
|
0.1736 USD |
|
2 years ago
Aug 31, 2022
|
Sell 501 K
USD
|
ZERCHER MICHAEL
President and COO
|
- 370789
|
1.35 USD |
|
2 years ago
Jun 14, 2022
|
Sell 34.4 K
USD
|
FRANZINO JOHN
Chief Administrative Officer
|
- 20324
|
1.6947 USD |
|
3 years ago
Dec 14, 2021
|
Sell 50 K
USD
|
ZERCHER MICHAEL
President and COO
|
- 23147
|
2.1617 USD |
|
3 years ago
Sep 30, 2021
|
Bought
57.6 K USD
|
MISH JAMES A
Chief Executive Officer
|
+ 20000
|
2.88 USD |
|
3 years ago
Jun 10, 2021
|
Sell 598 K
USD
|
FLEET CLIFFORD B
Director
|
- 125000
|
4.78 USD |
|
3 years ago
Mar 31, 2021
|
Bought
48.4 K USD
|
MISH JAMES A
Chief Executive Officer
|
+ 15000
|
3.23 USD |
|
3 years ago
Mar 31, 2021
|
Bought
48.4 K USD
|
MISH JAMES A
Chief Executive Officer
|
+ 15000
|
3.23 USD |
|
3 years ago
Mar 17, 2021
|
Sell 128 K
USD
|
SANDERS RICHARD M.
Director
|
- 47227
|
2.72 USD |
|
3 years ago
Mar 16, 2021
|
Bought
150 K USD
|
O'BRIEN ROGER D
Director
|
+ 52400
|
2.86 USD |
|
4 years ago
Nov 17, 2020
|
Bought
92.8 K USD
|
MISH JAMES A
Chief Executive Officer
|
+ 100000
|
0.928 USD |
|
4 years ago
Jun 29, 2020
|
Bought
17.2 K USD
|
SULLIVAN NORA B
Director
|
+ 22000
|
0.78 USD |
|
4 years ago
Jun 05, 2020
|
Bought
24.6 K USD
|
SULLIVAN NORA B
Director
|
+ 29953
|
0.82 USD |
|
4 years ago
Jun 04, 2020
|
Bought
58.7 K USD
|
SULLIVAN NORA B
Director
|
+ 71372
|
0.8219 USD |
|
5 years ago
Aug 27, 2019
|
Bought
141 K USD
|
FLEET CLIFFORD B
President and CEO
|
+ 75000
|
1.8773 USD |
|
5 years ago
Aug 26, 2019
|
Bought
49.2 K USD
|
FLEET CLIFFORD B
President and CEO
|
+ 25000
|
1.97 USD |
|
5 years ago
Jun 17, 2019
|
Sell 101 K
USD
|
JAMES THOMAS L.
VP, General Counsel & Sec'y.
|
- 48000
|
2.1083 USD |
|
6 years ago
Jun 29, 2018
|
Sell 122 K
USD
|
JAMES THOMAS L.
VP, General Counsel & Sec'y.
|
- 50000
|
2.4385 USD |
|
7 years ago
Sep 29, 2017
|
Sell 133 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 50000
|
2.6655 USD |
|
7 years ago
Jul 31, 2017
|
Sell 59.1 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 29532
|
2 USD |
|
7 years ago
Jun 08, 2017
|
Sell 40.9 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 20468
|
2 USD |
|
8 years ago
Oct 31, 2016
|
Sell 128 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 100000
|
1.2806 USD |
|
8 years ago
Mar 29, 2016
|
Bought
9.6 K USD
|
BRODFUEHRER JOHN T
CFO & Treasurer
|
+ 12500
|
0.7676 USD |
|
9 years ago
Nov 02, 2015
|
Sell 43.3 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 31060
|
1.3926 USD |
|
9 years ago
Nov 03, 2015
|
Sell 27 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 18940
|
1.4232 USD |
|
9 years ago
Jun 29, 2015
|
Sell 21.2 K
USD
|
Pandolfino Joseph
|
- 21000
|
1.01 USD |
|
9 years ago
Jun 30, 2015
|
Sell 65.4 K
USD
|
Pandolfino Joseph
|
- 70178
|
0.932 USD |
|
10 years ago
Dec 29, 2014
|
Sell 45.7 K
USD
|
Pandolfino Joseph
|
- 29124
|
1.57 USD |
|
10 years ago
Dec 30, 2014
|
Sell 29.7 K
USD
|
Pandolfino Joseph
|
- 18100
|
1.64 USD |
|
10 years ago
Dec 31, 2014
|
Sell 98.4 K
USD
|
Pandolfino Joseph
|
- 57900
|
1.7 USD |
|
10 years ago
Dec 23, 2014
|
Sell 3.2
USD
|
Pandolfino Joseph
|
- 2
|
1.6 USD |
|
10 years ago
Dec 24, 2014
|
Sell 23.6 K
USD
|
Pandolfino Joseph
|
- 15300
|
1.54 USD |
|
10 years ago
Dec 26, 2014
|
Sell 40.7 K
USD
|
Pandolfino Joseph
|
- 26420
|
1.54 USD |
|
10 years ago
Dec 18, 2014
|
Sell 15.6 K
USD
|
Pandolfino Joseph
|
- 9600
|
1.62 USD |
|
10 years ago
Dec 19, 2014
|
Sell 37.6 K
USD
|
Pandolfino Joseph
|
- 23500
|
1.6 USD |
|
10 years ago
Dec 22, 2014
|
Sell 30.9 K
USD
|
Pandolfino Joseph
|
- 19583
|
1.58 USD |
|
10 years ago
Dec 15, 2014
|
Sell 11 K
USD
|
Pandolfino Joseph
director, 10 percent owner:
|
- 6841
|
1.61 USD |
|
10 years ago
Dec 16, 2014
|
Sell 34.2 K
USD
|
Pandolfino Joseph
director, 10 percent owner:
|
- 21627
|
1.58 USD |
|
10 years ago
Dec 17, 2014
|
Sell 77.6 K
USD
|
Pandolfino Joseph
director, 10 percent owner:
|
- 47300
|
1.64 USD |
|
10 years ago
Dec 09, 2014
|
Sell 83.9 K
USD
|
Pandolfino Joseph
director, 10 percent owner:
|
- 51462
|
1.63 USD |
|
10 years ago
Dec 10, 2014
|
Sell 12.8 K
USD
|
Pandolfino Joseph
director, 10 percent owner:
|
- 7474
|
1.71 USD |
|
10 years ago
Dec 11, 2014
|
Sell 15.2 K
USD
|
Pandolfino Joseph
director, 10 percent owner:
|
- 8900
|
1.71 USD |
|
10 years ago
May 09, 2014
|
Bought
44.7 K USD
|
SANDERS RICHARD M.
Director
|
+ 20000
|
2.2328 USD |
|
10 years ago
Apr 21, 2014
|
Sell 119 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 46500
|
2.5556 USD |
|
10 years ago
Apr 22, 2014
|
Sell 69.4 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 29500
|
2.3522 USD |
|
10 years ago
Apr 23, 2014
|
Sell 55.5 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 24000
|
2.3105 USD |
|
10 years ago
Mar 10, 2014
|
Sell 393 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 65000
|
6.04 USD |
|
10 years ago
Mar 12, 2014
|
Sell 152 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 30000
|
5.05 USD |
|
11 years ago
Dec 10, 2013
|
Sell 15.5 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 10000
|
1.55 USD |
|
11 years ago
Dec 10, 2013
|
Sell 15.5 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 10000
|
1.55 USD |
|
11 years ago
Dec 09, 2013
|
Sell 1.45 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 1000
|
1.45 USD |
|
11 years ago
Dec 09, 2013
|
Sell 14.7 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 10000
|
1.47 USD |
|
11 years ago
Dec 09, 2013
|
Sell 5.92 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 4000
|
1.48 USD |
|
11 years ago
Dec 02, 2013
|
Sell 9.68 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 7173
|
1.35 USD |
|
11 years ago
Dec 03, 2013
|
Sell 3.82 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 2827
|
1.35 USD |
|
11 years ago
Dec 02, 2013
|
Sell 9.68 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 7173
|
1.35 USD |
|
11 years ago
Dec 03, 2013
|
Sell 3.82 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 2827
|
1.35 USD |
|
11 years ago
Nov 21, 2013
|
Bought
5.9 K USD
|
BRODFUEHRER JOHN T
CFO & Treasurer
|
+ 5000
|
1.18 USD |
|
11 years ago
Nov 21, 2013
|
Bought
3.57 K USD
|
BRODFUEHRER JOHN T
CFO & Treasurer
|
+ 3000
|
1.19 USD |
|
11 years ago
Nov 21, 2013
|
Bought
2.28 K USD
|
BRODFUEHRER JOHN T
CFO & Treasurer
|
+ 2000
|
1.14 USD |
|
11 years ago
Nov 18, 2013
|
Sell 10 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 10000
|
1 USD |
|
11 years ago
Nov 18, 2013
|
Sell 4.26 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 4174
|
1.02 USD |
|
11 years ago
Nov 19, 2013
|
Sell 18.4 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 15900
|
1.16 USD |
|
11 years ago
Nov 18, 2013
|
Sell 10 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 10000
|
1 USD |
|
11 years ago
Nov 18, 2013
|
Sell 4.26 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 4174
|
1.02 USD |
|
11 years ago
Nov 19, 2013
|
Sell 18.4 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 15900
|
1.16 USD |
|
11 years ago
Nov 12, 2013
|
Sell 6.65 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 7000
|
0.95 USD |
|
11 years ago
Nov 13, 2013
|
Sell 4.92 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 4826
|
1.02 USD |
|
11 years ago
Nov 12, 2013
|
Sell 6.65 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 7000
|
0.95 USD |
|
11 years ago
Nov 13, 2013
|
Sell 4.92 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 4826
|
1.02 USD |
|
11 years ago
Nov 07, 2013
|
Sell 116
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 100
|
1.16 USD |
|
11 years ago
Nov 11, 2013
|
Sell 7.21 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 7000
|
1.03 USD |
|
11 years ago
Nov 07, 2013
|
Sell 116
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 100
|
1.16 USD |
|
11 years ago
Nov 11, 2013
|
Sell 7.21 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 7000
|
1.03 USD |
|
11 years ago
Nov 06, 2013
|
Sell 4.64 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 4000
|
1.16 USD |
|
11 years ago
Nov 07, 2013
|
Sell 5.7 K
USD
|
SAFFIRE RICHARD G
10 percent owner
|
- 5000
|
1.14 USD |
|
11 years ago
Nov 06, 2013
|
Sell 4.64 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 4000
|
1.16 USD |
|
11 years ago
Nov 07, 2013
|
Sell 5.7 K
USD
|
Clearwater Partners, LLC
10 percent owner
|
- 5000
|
1.14 USD |
|
11 years ago
Oct 18, 2013
|
Sell 68 K
USD
|
Dunn Joseph A
Director
|
- 60000
|
1.1329 USD |
|
11 years ago
Aug 13, 2013
|
Sell 5.2 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 5000
|
1.04 USD |
|
11 years ago
Aug 13, 2013
|
Sell 4.57 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 4315
|
1.06 USD |
|
11 years ago
Aug 14, 2013
|
Sell 2.12 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 2000
|
1.06 USD |
|
11 years ago
Aug 14, 2013
|
Sell 3.94 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 3685
|
1.07 USD |
|
11 years ago
Jun 25, 2013
|
Sell 71.8 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 102600
|
0.7 USD |
|
11 years ago
Jun 26, 2013
|
Sell 24.5 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 35000
|
0.7 USD |
|
11 years ago
Jun 27, 2013
|
Sell 42.6 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 60000
|
0.71 USD |
|
11 years ago
May 17, 2013
|
Sell 2.95 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 5000
|
0.59 USD |
|
11 years ago
May 20, 2013
|
Sell 3 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 5000
|
0.6 USD |
|
11 years ago
May 21, 2013
|
Sell 3 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 5000
|
0.6 USD |
|
11 years ago
Mar 28, 2013
|
Sell 4 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 5000
|
0.8 USD |
|
11 years ago
Mar 26, 2013
|
Sell 4.15 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 5000
|
0.83 USD |
|
11 years ago
Mar 27, 2013
|
Sell 4 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 4500
|
0.888 USD |
|
11 years ago
Mar 27, 2013
|
Sell 455
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 500
|
0.91 USD |
|
12 years ago
Nov 26, 2012
|
Bought
16 K USD
|
SICIGNANO HENRY III
CFO, President, Secretary
|
+ 100000
|
0.16 USD |
|
12 years ago
Nov 26, 2012
|
Bought
17 K USD
|
SICIGNANO HENRY III
CFO, President, Secretary
|
+ 100000
|
0.17 USD |
|
12 years ago
Nov 19, 2012
|
Bought
8.8 K USD
|
SICIGNANO HENRY III
CFO, President, Secretary
|
+ 40000
|
0.22 USD |
|
12 years ago
Nov 19, 2012
|
Sell 8.8 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 40000
|
0.22 USD |
|
12 years ago
Nov 09, 2012
|
Bought
150 K USD
|
SICIGNANO HENRY III
CFO, President, Secretary
|
+ 600000
|
0.25 USD |
|
12 years ago
Nov 09, 2012
|
Bought
300 K USD
|
SICIGNANO HENRY III
CFO, President, Secretary
|
+ 300000
|
1 USD |
|
12 years ago
Nov 09, 2012
|
Bought
120 K USD
|
Pandolfino Joseph
Chief Executive Officer
|
+ 480000
|
0.25 USD |
|
12 years ago
Nov 09, 2012
|
Bought
240 K USD
|
Pandolfino Joseph
Chief Executive Officer
|
+ 240000
|
1 USD |
|
12 years ago
Nov 09, 2012
|
Bought
15 K USD
|
Cornell James W
Director
|
+ 60000
|
0.25 USD |
|
12 years ago
Nov 09, 2012
|
Bought
30 K USD
|
Cornell James W
Director
|
+ 30000
|
1 USD |
|
12 years ago
Nov 09, 2012
|
Bought
15 K USD
|
Dunn Joseph A
Director
|
+ 60000
|
0.25 USD |
|
12 years ago
Nov 09, 2012
|
Bought
30 K USD
|
Dunn Joseph A
Director
|
+ 30000
|
1 USD |
|
12 years ago
Aug 27, 2012
|
Sell 5.02 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 20100
|
0.25 USD |
|
12 years ago
Aug 28, 2012
|
Sell 5.5 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 22000
|
0.25 USD |
|
12 years ago
Aug 29, 2012
|
Sell 37.5 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 150000
|
0.25 USD |
|
12 years ago
Aug 30, 2012
|
Sell 1.5 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 5000
|
0.3 USD |
|
12 years ago
Aug 28, 2012
|
Bought
1.88 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 7500
|
0.25 USD |
|
12 years ago
Aug 27, 2012
|
Bought
1.28 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 5100
|
0.25 USD |
|
12 years ago
Aug 20, 2012
|
Bought
2.48 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 9900
|
0.25 USD |
|
12 years ago
Aug 21, 2012
|
Sell 25
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 100
|
0.25 USD |
|
12 years ago
Aug 21, 2012
|
Sell 1.4 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 5000
|
0.28 USD |
|
12 years ago
Aug 22, 2012
|
Sell 5.11 K
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 14605
|
0.35 USD |
|
12 years ago
Aug 22, 2012
|
Sell 88.5
USD
|
Moynihan Michael Robert
Vice President of R&D
|
- 295
|
0.3 USD |
|
12 years ago
May 15, 2012
|
Bought
90 K USD
|
Moynihan Michael Robert
Vice President of R&D
|
+ 150000
|
0.6 USD |
|
12 years ago
May 15, 2012
|
Bought
150 K USD
|
Moynihan Michael Robert
Vice President of R&D
|
+ 150000
|
1 USD |
|
12 years ago
May 15, 2012
|
Bought
7.2 K USD
|
RIDER CHARLES ANTHONY
CFO and Treasurer
|
+ 12000
|
0.6 USD |
|
12 years ago
May 15, 2012
|
Bought
12 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 20000
|
0.6 USD |
|
12 years ago
May 15, 2012
|
Bought
20 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 20000
|
1 USD |
|
12 years ago
May 15, 2012
|
Bought
7.2 K USD
|
Pandolfino Joseph
Chief Executive Officer
|
+ 12000
|
0.6 USD |
|
12 years ago
May 15, 2012
|
Bought
12 K USD
|
Pandolfino Joseph
Chief Executive Officer
|
+ 12000
|
1 USD |
|
13 years ago
Nov 17, 2011
|
Bought
100 K USD
|
TOMASELLO ANGELO J
10 percent owner
|
+ 143000
|
0.7 USD |
|
13 years ago
Nov 17, 2011
|
Sell 100 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 143000
|
0.7 USD |
|
13 years ago
Sep 21, 2011
|
Bought
7.8 K USD
|
TOMASELLO ANGELO J
10 percent owner
|
+ 10000
|
0.78 USD |
|
13 years ago
Jun 07, 2011
|
Bought
113 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 110000
|
1.03 USD |
|
13 years ago
May 31, 2011
|
Bought
2.44 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 2000
|
1.22 USD |
|
13 years ago
May 26, 2011
|
Bought
1.15 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 1000
|
1.15 USD |
|
13 years ago
Apr 11, 2011
|
Bought
6.25 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 5000
|
1.25 USD |
|
13 years ago
May 03, 2011
|
Bought
3.75 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 3000
|
1.25 USD |
|
13 years ago
Apr 04, 2011
|
Bought
1.8 K USD
|
SICIGNANO HENRY III
President, Secretary
|
+ 1500
|
1.2 USD |
|
13 years ago
Jun 07, 2011
|
Sell 113 K
USD
|
Pandolfino Joseph
Chief Executive Officer
|
- 110000
|
1.03 USD |
7. News
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII)
Sheridan, Wyoming--(Newsfile Corp. - February 19, 2025) - Emerging Growth Research is pleased to announce the release of its new initiation report on the 22nd Century Group, Inc. (NASDAQ: XXII). The Company has made significant strides in its operational and financial restructuring under new management, with only the warrant overhang remaining to be addressed.
newsfilecorp.com
- 1 week ago
22nd Century to Present at the Emerging Growth Conference on February 19, 2025
MOCKSVILLE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) is pleased to announce that Larry Firestone, Chief Executive Officer, will present at the Emerging Growth Conference on Wednesday, February 19, 2025, at 10:50 am Eastern Time.
globenewswire.com
- 3 weeks ago
22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards
MOCKSVILLE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it has received formal written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the Nasdaq Minimum Bid Price Requirement for continued listing pursuant to Nasdaq Listing Rule 5550(a)(2).
globenewswire.com
- 1 month ago
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cigarette That Complies with the New Standard
New FDA Rule Cites Extensive Research Using 22nd Century Manufactured Products and Specifically Cites 22nd Century VLN Sales Activity
globenewswire.com
- 1 month ago
Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers
VLN Reduced Nicotine Content Cigarettes from 22nd Century Is the Only Authorized Combustible Solution to Support the FDA's War on Smoking
globenewswire.com
- 1 month ago
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes
FDA Reduced Nicotine Content Proposal Indicated to Have Completed OMB Review as of January 3, 2025 FDA Spokesperson Indicates Policy Could Be Among Most Impactful Population-Level Actions in the History of U.S. Tobacco Product Regulation MOCKSVILLE, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it stands ready to support the U.S. Food and Drug Administration's proposed tobacco product standard to mandate reduced nicotine content in cigarettes, which is indicated to have cleared review by the U.S. Office of Management and Budget on January 3, 2025.
globenewswire.com
- 1 month ago
22nd Century Group Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly
Agreement covers 11 existing brands, supports launch 8 additional premium brands with Smoker Friendly retail and dealer locations
globenewswire.com
- 1 month ago
22nd Century Announces 1-for-135 Reverse Stock Split
Mocksville, North Carolina--(Newsfile Corp. - December 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it will effect a reverse stock split of its outstanding shares of common stock, par value $0.00001 per share (the "Common Stock"), at a ratio of 1-for-135, to be effective as of December 17, 2024. The reverse stock split is intended for the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on Nasdaq.
newsfilecorp.com
- 2 months ago
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes
Recent FDA Action Advances Policy Proposal That Originated During First Trump Administration and Continued to Progress Under Biden Administration Mocksville, North Carolina--(Newsfile Corp. - December 12, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it applauds action by the U.S. Food and Drug Administration to advance its long-standing proposal mandating a drastic reduction in the amount of nicotine in cigarettes, a cornerstone goal of public health experts seeking to reduce the harms of smoking. "We are excited to see definitive action by the FDA intended to advance its scientifically backed reduced nicotine content mandate for cigarette products, a non-partisan proposal that actually began moving forward during the first Trump administration and continued its progress during the Biden administration," said Larry Firestone, Chief Executive Officer of 22nd Century Group.
newsfilecorp.com
- 2 months ago
22nd Century Group Reports Third Quarter 2024 Financial Results
Remains on Path to Cash Positive Operations in Q1 2025 Commencing Growth Strategy Leveraging Both Internal and External Brand Assets Across Multiple Categories Mocksville, North Carolina--(Newsfile Corp. - November 12, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced results for the third quarter ended September 30, 2024, and provided an update on recent business highlights. Third Quarter 2024 Financial Results (compared to Second Quarter 2024, except as noted) All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of the Company's hemp/cannabis business in late 2023.
newsfilecorp.com
- 3 months ago
22nd Century Group (XXII) to Announce Third Quarter 2024 Results on November 12, 2024
Mocksville, North Carolina--(Newsfile Corp. - November 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, will host a webcast on Wednesday, November 12, 2024, at 8:00 AM ET to discuss its 2024 third quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.
newsfilecorp.com
- 3 months ago
22nd Century Group to Present at the LD Micro Main Event XVII on October 30 in Los Angeles
Mocksville, North Carolina--(Newsfile Corp. - October 21, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it will be presenting at the LD Micro Main Event XVII investor conference to be held October 28-30, 2024 in Los Angeles. As part of the conference, the Company will conduct a group presentation at 3:30 pm Pacific Time on Wednesday, October 30, 2024.
newsfilecorp.com
- 4 months ago
8. Profile
Summary
22nd Century Group, Inc. XXII
COUNTRY
US
INDUSTRY
Tobacco
MARKET CAP
$ 3.29 M
Dividend Yield
0.00%
Description
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Contact
500 Seneca Street, Buffalo, NY, 14204
https://www.xxiicentury.com
IPO
Date
Jan. 26, 2011
Employees
64
Officers
Mr. James C. Morrison
Technical Advisor & Regulatory Affairs Consultant
Mr. Lawrence D. Firestone
President, Chief Executive Officer & Chairman
Mr. Daniel A. Otto
Chief Financial Officer & Principal Accounting Officer
Mr. Jonathan Staffeldt
General Counsel & Secretary
Mr. Robert P. Manfredonia
Executive Vice President of Sales and Marketing
Matthew Kreps
Investor Relations
Mr. Scott Marion
Vice President of Operations